What Alopecia Areata Is
Alopecia areata is generally understood as an immune-mediated condition in which the hair follicle's normally immune-privileged environment breaks down, allowing immune activity to affect the follicle.
How the Immune Privilege Is Thought to Break Down
This immune privilege is thought to depend on mechanisms such as limited antigen presentation by follicle cells, and its disruption is associated with immune cell infiltration around affected follicles.
What's Still Being Studied
Researchers are actively studying related biological factors, such as scalp/gut microbiome associations and broader hair follicle cycling biology, as areas of ongoing interest rather than established interventions.
Why This Is a Referral, Not a Salon, Condition
Alopecia areata is addressed through structured, evidence-graded, multidisciplinary clinical guidelines and patient resources, reflecting that this is a medically managed condition best handled through referral to dermatology rather than salon-based intervention.
What this page can — and cannot — tell you
Scope: This page is intended to give beauty and scalp-care practitioners a conceptual, non-diagnostic, non-treatment understanding of alopecia areata as an immune-mediated condition and to support appropriate referral to dermatology; it deliberately excludes diagnostic criteria, medication/treatment protocols, and product or procedural recommendations, which are outside AIMT's observational education scope for this page.
Clinical guidance for alopecia areata is a living document oriented to a specific health system (UK NHS) and is expected to keep evolving as new evidence emerges, so general awareness content should not be read as fixed or universally applicable.
Microbiome-alopecia association research is based on heterogeneous, largely small studies, and causality between microbiome changes and alopecia areata has not been established.
Much of the detailed knowledge about hair follicle biology and cycling comes from animal models and narrative reviews, with incomplete validation in humans.
Key takeaways
-
01
Alopecia areata is generally understood as an immune-mediated condition in which the hair follicle's normally immune-privileged environment breaks down, allowing immune activity to affect the follicle.
-
02
Alopecia areata is addressed through structured, evidence-graded, multidisciplinary clinical guidelines and patient resources, reflecting that this is a medically managed condition best handled through referral to dermatology rather than salon-based intervention.
-
03
Researchers are actively studying related biological factors, such as scalp/gut microbiome associations and broader hair follicle cycling biology, as areas of ongoing interest rather than established interventions.
Sources & references
The cleared source set supporting this page's evidence review.
- Alexis E. Carrington, Jessica Maloh, Yvonne Nong, Oma N. Agbai, Apple A. Bodemer, Raja K. Sivamani. The Gut and Skin Microbiome in Alopecia: Associations and Interventions
- Matthew J. Harries, Alia Ahmed, Anna Ascott, Kashif Bhatti, Joseph Earley, Paul Farrant, Susan Holmes, Amy Johnson, Abby E. Macbeth, Andrew G. Messenger, Julian Pearce, Anita Takwale, Andrew R. Thompson, Maria Hashme, M. Firouz Mohd Mustapa, Alina M. Constantin. British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Marta Bertolini, Kevin McElwee, Amos Gilhar, Silvia Bulfone-Paus, Ralf Paus. Hair follicle immune privilege and its collapse in alopecia areata
- Artem Kiselev, Sangbum Park. Immune niches for hair follicle development and homeostasis
- Rohan R. Shah, Jorge Larrondo, Thomas Dawson, Amy McMichael. Scalp microbiome: a guide to better understanding scalp diseases and treatments
- Chew Teng Tan, Chin Yan Lim, Kenneth Lay. Modelling Human Hair Follicles—Lessons from Animal Models and Beyond